Lillian L. Siu, MD, on Liquid KRAS Mutation Screening in Patients With Advanced Pancreatic Cancer
Lillian L. Siu, MD, of Princess Margaret Cancer Centre, discusses the clinical utility of liquid biopsy testing for common KRAS variants to facilitate matching patients with pancreatic ductal adenocarcinoma to appropriate early-phase trials (Abstract 3049).